Publications by authors named "Claudia Polloni"

Claim this Profile
A
Assessment of vulnerability measures and their effect on survival in a real-life population of multiple myeloma patients registered at Marche Region Multiple Myeloma Registry.
Massimo Offidani, Laura Corvatta, Claudia Polloni, Riccardo Centurioni, Giuseppe Visani

Clin Lymphoma Myeloma Leuk· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of melphalan, thalidomide and prednisone combined with oral panobinostat in patients with relapsed/refractory multiple myeloma.
Massimo Offidani, Claudia Polloni, Federica Cavallo, Anna Marina Liberati, Stelvio Ballanti

Leuk Lymphoma· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thalidomide, dexamethasone, Doxil and Velcade (ThaDD-V) followed by consolidation/maintenance therapy in patients with relapsed-refractory multiple myeloma.
Massimo Offidani, Laura Corvatta, Claudia Polloni, Silvia Gentili, Anna Mele

Ann Hematol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infectious complications in patients with multiple myeloma treated with new drug combinations containing thalidomide.
Massimo Offidani, Laura Corvatta, Claudia Polloni, Silvia Gentili, Annamaria Brioni

Leuk Lymphoma· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial.
Antonio Palumbo, Michele Cavo, Sara Bringhen, Elena Zamagni, Alessandra Romano, Claudia Polloni

J Clin Oncol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome and toxicity in the modern era of new drugs for multiple myeloma: a reappraisal for comparison with future investigational trials.
Massimo Offidani, Pietro Leoni, Laura Corvatta, Claudia Polloni, Silvia Gentili

Clin Lymphoma Myeloma Leuk· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melphalan, prednisone, and thalidomide versus thalidomide, dexamethasone, and pegylated liposomal doxorubicin regimen in very elderly patients with multiple myeloma: a case-match study.
Massimo Offidani, Pietro Leoni, Sara Bringhen, Laura Corvatta, Alessandra Larocca, Claudia Polloni

Leuk Lymphoma· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
ThaDD plus high dose therapy and autologous stem cell transplantation does not appear superior to ThaDD plus maintenance in elderly patients with de novo multiple myeloma.
Massimo Offidani, Pietro Leoni, Laura Corvatta, Claudia Polloni, Silvia Gentili

Eur J Haematol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thalidomide-dexamethasone versus interferon-alpha-dexamethasone as maintenance treatment after ThaDD induction for multiple myeloma: a prospective, multicentre, randomised study.
Massimo Offidani, Laura Corvatta, Claudia Polloni, Maria-Novella Piersantelli, Silvia Gentili

Br J Haematol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum C-reactive protein at diagnosis and response to therapy is the most powerful factor predicting outcome of multiple myeloma treated with thalidomide/ anthracycline-based therapy.
Massimo Offidani, Laura Corvatta, Claudia Polloni, Maria-Novella Piersantelli, Piero Galieni

Clin Lymphoma Myeloma· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thalidomide-dexamethasone plus pegylated liposomal doxorubicin vs. thalidomide-dexamethasone: a case-matched study in advanced multiple myeloma.
Massimo Offidani, Sara Bringhen, Laura Corvatta, Patrizia Falco, Monica Marconi, Claudia Polloni

Eur J Haematol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma.
Massimo Offidani, Laura Corvatta, Maria-Novella Piersantelli, Giuseppe Visani, Francesco Alesiani, Claudia Polloni

Blood· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis